Leukocyte-mediated endothelial cell injury and death in the diabetic retina

被引:494
作者
Joussen, AM
Murata, T
Tsujikawa, A
Kirchhof, B
Bursell, SE
Adamis, AP
机构
[1] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA
[2] Harvard Univ, Childrens Hosp, Sch Med, Surg Res Lab, Boston, MA 02115 USA
[3] Rhein Westfal TH Aachen, Dept Ophthalmol, D-5100 Aachen, Germany
[4] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA
关键词
D O I
10.1016/S0002-9440(10)63952-1
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Endothelial cell death is a hallmark of diabetic retinopathy. Its occurrence is required for the formation of acellular (devitalized) capillaries, lesions that produce irreversible retinal ischemia through their inability to support blood now. The mechanisms underlying diabetic retinal endothelial cell injury and death remain largely unknown. The current study demonstrates that adherent leukocytes are temporally and spatially associated with retinal endothelial cell injury and death within 1 week of streptozotocin-induced experimental diabetes in rats. Moreover, the antibody-based neutralization of intercellular adhesion molecule-1 and CD18 is shown to prevent both leukocyte adhesion and retinal endothelial cell injury and death. These data highlight the central and causal role of adherent leukocytes in the pathogenesis of diabetic retinopathy. They also underscore the potential utility of anti-intercellular adhesion molecule1- and anti-CD18-based therapies in the treatment of diabetic retinopathy, a newly recognized inflammatory disease.
引用
收藏
页码:147 / 152
页数:6
相关论文
共 15 条
  • [1] Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate
    Adamis, AP
    Shima, DT
    Tolentino, MJ
    Gragoudas, ES
    Ferrara, N
    Folkman, J
    DAmore, PA
    Miller, JW
    [J]. ARCHIVES OF OPHTHALMOLOGY, 1996, 114 (01) : 66 - 71
  • [2] SUPPRESSION OF RETINAL NEOVASCULARIZATION IN-VIVO BY INHIBITION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) USING SOLUBLE VEGF-RECEPTOR CHIMERIC PROTEINS
    AIELLO, LP
    PIERCE, EA
    FOLEY, ED
    TAKAGI, H
    CHEN, H
    RIDDLE, L
    FERRARA, N
    KING, GL
    SMITH, LEH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (23) : 10457 - 10461
  • [3] Barouch FC, 2000, INVEST OPHTH VIS SCI, V41, P1153
  • [4] Attenuation of oxygen free radical formation and tissue injury during experimental inflammation by P-selectin blockade
    Delano, FA
    Forrest, MJ
    SchmidSchonbein, GW
    [J]. MICROCIRCULATION-LONDON, 1997, 4 (03): : 349 - 357
  • [5] A SUBPOPULATION OF MAC-1 (CD11B/CD18) MOLECULES MEDIATES NEUTROPHIL ADHESION TO ICAM-1 AND FIBRINOGEN
    DIAMOND, MS
    SPRINGER, TA
    [J]. JOURNAL OF CELL BIOLOGY, 1993, 120 (02) : 545 - 556
  • [6] ALDOSE REDUCTASE INHIBITION - THE CHEMICAL KEY TO THE CONTROL OF DIABETIC-RETINOPATHY
    FRANK, R
    [J]. ARCHIVES OF OPHTHALMOLOGY, 1990, 108 (09) : 1229 - 1231
  • [7] AMINOGUANIDINE TREATMENT INHIBITS THE DEVELOPMENT OF EXPERIMENTAL DIABETIC-RETINOPATHY
    HAMMES, HP
    MARTIN, S
    FEDERLIN, K
    GEISEN, K
    BROWNLEE, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (24) : 11555 - 11558
  • [8] HAUGLAND RP, 1906, HDB FLUORESCENT PROB, P149
  • [9] VASCULAR-LESIONS IN DIABETES ARE DISTRIBUTED NONUNIFORMLY WITHIN THE RETINA
    KERN, TS
    ENGERMAN, RL
    [J]. EXPERIMENTAL EYE RESEARCH, 1995, 60 (05) : 545 - 549
  • [10] MCLEOD DS, 1995, AM J PATHOL, V147, P642